by Gonzalo Payan | Feb 27, 2024
MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies : https://www.prnewswire.com/news-releases/max-biopharma-and-metaba-announce-collaboration-on-metabolomics-studies-302070283.htmlby Gonzalo Payan | Feb 27, 2024
MAX BioPharma will be attending Biocom’s Global Life Science Partnering & Investor conference scheduled for February 27th – February 29th in La Jolla, California. The Company’s Founder, President & CEO, Farhad Parhami, will present the latest news on its...by Gonzalo Payan | Feb 3, 2023
MAX BioPharma will be attending Biocom’s Global Life Science Partnering & Investor conference scheduled for February 28th – March 2nd. The Company’s Founder & CEO, Farhad Parhami, is scheduled to present the latest news on its pipeline and...by Gonzalo Payan | Feb 3, 2023
MAX BioPharma reports on the inhibition of profibrotic signaling in cellular models of lung and kidney fibrosis by its oxysterol drug candidate, Oxy210, an orally available small molecule. Please follow the link for a copy of the manuscript....by Gonzalo Payan | May 18, 2022
MAX BioPharma reports on the anti-inflammatory effects of its oxysterol drug candidate, Oxy210, an orally available small moleculedifferent from steroids and NSAIDs. Please follow the link for a copy of the manuscript....